NanoRepro Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for NanoRepro.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 14.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Cautious Investors Not Rewarding NanoRepro AG's (ETR:NN6) Performance Completely
Mar 01The Market Lifts NanoRepro AG (ETR:NN6) Shares 28% But It Can Do More
Sep 13A Look At The Intrinsic Value Of NanoRepro AG (ETR:NN6)
Aug 04NanoRepro (ETR:NN6) Is Experiencing Growth In Returns On Capital
Apr 12NanoRepro (ETR:NN6) Is Doing The Right Things To Multiply Its Share Price
Dec 15Robust Earnings May Not Tell The Whole Story For NanoRepro (ETR:NN6)
May 29NanoRepro AG's (ETR:NN6) Stock Is Going Strong: Have Financials A Role To Play?
Jan 04In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as NanoRepro has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 4 | -3 | N/A | N/A | N/A |
3/31/2024 | 3 | -4 | N/A | N/A | N/A |
12/31/2023 | 3 | -5 | -10 | -10 | N/A |
9/30/2023 | 9 | -6 | N/A | N/A | N/A |
6/30/2023 | 14 | -7 | 5 | 8 | N/A |
3/31/2023 | 27 | -5 | 7 | 11 | N/A |
12/31/2022 | 39 | -4 | 10 | 13 | N/A |
9/30/2022 | 54 | 0 | N/A | N/A | N/A |
6/30/2022 | 69 | 4 | N/A | N/A | N/A |
3/31/2022 | 116 | 17 | N/A | N/A | N/A |
12/31/2021 | 163 | 30 | 8 | 8 | N/A |
9/30/2021 | 149 | 29 | N/A | N/A | N/A |
6/30/2021 | 135 | 27 | N/A | N/A | N/A |
3/31/2021 | 76 | 14 | N/A | N/A | N/A |
12/31/2020 | 17 | 2 | -1 | -1 | N/A |
9/30/2020 | 10 | 1 | N/A | N/A | N/A |
6/30/2020 | 3 | 0 | N/A | N/A | N/A |
3/31/2020 | 2 | -1 | N/A | N/A | N/A |
12/31/2019 | 2 | -1 | -1 | -1 | N/A |
9/30/2019 | 2 | -1 | N/A | N/A | N/A |
6/30/2019 | 2 | -1 | N/A | N/A | N/A |
3/31/2019 | 2 | -1 | N/A | N/A | N/A |
12/31/2018 | 3 | 0 | -1 | 0 | N/A |
9/30/2018 | 3 | 0 | N/A | N/A | N/A |
6/30/2018 | 3 | -1 | N/A | N/A | N/A |
3/31/2018 | 2 | -1 | N/A | N/A | N/A |
12/31/2017 | 2 | -1 | N/A | -1 | N/A |
9/30/2017 | 2 | -1 | N/A | N/A | N/A |
6/30/2017 | 2 | 0 | N/A | N/A | N/A |
3/31/2017 | 2 | -1 | N/A | N/A | N/A |
12/31/2016 | 2 | -1 | N/A | -1 | N/A |
9/30/2016 | 1 | -1 | N/A | N/A | N/A |
6/30/2016 | 1 | -1 | N/A | N/A | N/A |
3/31/2016 | 1 | -1 | N/A | N/A | N/A |
12/31/2015 | 1 | -1 | N/A | -1 | N/A |
9/30/2015 | 1 | -1 | N/A | N/A | N/A |
6/30/2015 | 1 | -1 | N/A | N/A | N/A |
3/31/2015 | 1 | 0 | N/A | N/A | N/A |
12/31/2014 | 1 | 0 | N/A | -1 | N/A |
9/30/2014 | 1 | 0 | N/A | N/A | N/A |
6/30/2014 | 0 | 0 | N/A | N/A | N/A |
3/31/2014 | 1 | 0 | N/A | N/A | N/A |
12/31/2013 | 2 | 0 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NN6's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if NN6's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if NN6's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if NN6's revenue is forecast to grow faster than the German market.
High Growth Revenue: Insufficient data to determine if NN6's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NN6's Return on Equity is forecast to be high in 3 years time